TD Cowen Raises Adaptive Biotechnologies Price Target to $32 From $28
TD Cowen maintained its Buy rating on Adaptive Biotechnologies while raising its price target from $28 to $32 per share.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.